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 Background: Pain and surgical stress cause a pro-inflammatory response followed by downregulation of the immune re-
sponse, which can increase the incidence of postoperative complications, such as infections or prolonged wound 
healing. T lymphocytes and natural killer (NK) cells have cytotoxic potential and are crucial components of cel-
lular immunity, which is important for maintenance of immune balance. The aim of this study was to analyze 
the effects of 3 types of postoperative analgesia on the preservation and cytotoxic potential of T lymphocytes, 
NK cells, and their subpopulations, as well as NKT cells, in patients after total knee replacement (TKR) to find 
the most effective analgesic technique for mitigating immune suppression.
 Material/Methods: Forty-eight patients scheduled for TKR were randomly allocated to Group 1 (patients received epidural anal-
gesia), Group 2 (patients received sciatic and femoral nerve block), or Group 3 (patients received multimodal 
systemic analgesia). Pain intensity was assessed at rest and on movement before, immediately after, and at 
24 and 72 h after surgery. Blood samples were collected at the same time points and peripheral blood mono-
nuclear cells were isolated. The frequencies of T lymphocytes, NK cells, and NKT cells, as well as their perforin 
expression, were simultaneously detected and analyzed by flow cytometry.
 Results: Patients in Group 1 and Group 2 experienced less severe pain than those in Group 3. The frequencies and per-
forin levels of T lymphocytes, their subsets, and NKT cells were significantly lower in Group 3 than in Group 1 
and Group 2.
 Conclusions: The present study confirmed that regional analgesia is more effective in maintaining cell-mediated immunity 
and perforin expression in peripheral blood lymphocytes in patients after TKR.
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Background
Total knee replacement (TKR) is a common orthopedic recon-
structive surgical procedure that improves the mobility and the 
quality of life in patients with degenerative osteoarthritis [1]. 
It is generally associated with strong postoperative pain at 
the surgical site [1]. Endogenous danger-associated molecular 
patterns produced and released after the tissue injury are rec-
ognized by pattern recognition receptors, such as Toll-like re-
ceptors (TLRs), expressed on the surface of local antigen-pre-
senting immune cells and non-immune cells, including primary 
sensory neurons, synoviocytes, fibroblasts, chondroblasts, and 
osteoblasts [2]. After engagement of the TLRs, the joint cells 
support the immune response by secreting cytokines, lead-
ing to local and systemic pro-inflammatory states [3], which 
cause pain [4]. Clinically manifested pain sensation is medi-
ated by an increase in pro-inflammatory cytokines and che-
mokines, such as interleukin (IL)-1, IL-6, IL-8, IL-17, and tumor 
necrosis factor-alpha (TNF-a), in body fluids [5]. IL-6 is posi-
tively correlated with IL-17 and Western Ontario and McMaster 
Universities Arthritis Index [5], and IL-8 amplifies the pain me-
diated by IL-6 and IL-17 [6]. Periodically increased serum TNF-a 
in osteoarthritis patients is also correlated with pain sensa-
tion [7]. Additionally, IL-17 enhances the expression of main 
pro-inflammatory mediators IL-1, IL-6, IL-8, TNF-a, C-reactive 
protein, monocyte chemo-attractant protein 1, and matrix me-
talloproteinases, and supports the recruitment of neutrophils, 
CD4+ and CD8+ T lymphocytes, and monocytes toward local 
inflammatory sites [7]. Cytokines have an immunoregulato-
ry function and are main mediators between the central ner-
vous and immune systems [8,9]. Circulating cytokines pass di-
rectly through the blood–brain barrier by active transport or 
indirectly by stimulation of the vagal nerve [10]. In the brain, 
cytokines change the concentration of neurotransmitters [11] 
and play a key role in the activation of the hypothalamic-pitu-
itary-adrenal axis as observed in stressed and depressed pa-
tients [12]. Pain increases neuroendocrine activation and cate-
cholamine release [12–16], which potentiate the inflammatory 
response [12]. Catecholamines inhibit T lymphocyte immune 
function and decrease NK cell activity directly through b-adren-
ergic receptors or indirectly by inhibiting cytokines, such as IL-
12 and interferon-g, which are essential for their activity [15].
Since surgical trauma and pain suppress cellular and humoral 
immunity in postoperative patients, effective anesthesia and 
postoperative analgesia are critical. Major surgical procedures, 
such as TKR, are associated with neuroendocrine, metabolic, 
and immunological alterations that result from tissue damage, 
anesthesia, and pain [17,18]. If not effectively treated post-
operatively, pain could additionally suppress the immune re-
sponse, causing delayed wound healing, infection, and poor 
outcomes. Therefore, the most effective analgesia technique 
with minor side effects is required.
Different types of anesthesia and postoperative analgesia in pa-
tients undergoing surgery have been shown to maintain a bet-
ter balance of cellular and humoral immunity [19]. Intravenous 
analgesia with opioids can attenuate postoperative pain, but 
there is strong evidence that it downregulates the immune re-
sponse and leads to higher incidence of complication and pro-
longed recovery [20,21]. Recently, it has been shown that re-
gional analgesia techniques can reduce the pro-inflammatory 
response caused by surgery and pain [12,22,23], but little is 
known about their effect on cell immunity and its cytotoxic po-
tential, which is important for wound healing and prevention 
of infections, particularly in patients undergoing TKR. T lym-
phocytes, natural killer (NK), and NKT cells have cytotoxic po-
tential; upon stimulation, they induce apoptosis and necrosis 
by secreting cytotoxic mediators, such as perforin, which form 
pores in the target cell membrane [24]. Perforin, also called cy-
tolisin, is a 66–70-kDa glycoprotein stored in granules in the 
cytotoxic lymphocytes and released from the granules at the 
immunological synapse [25].
This study aimed to find the most effective analgesic tech-
nique – epidural analgesia vs. peripheral nerve blockade of 
sciatic and femoral nerves vs. multimodal systemic analgesia 
– for preserving perforin-expressing T lymphocytes, NK, and 
NKT cells in peripheral blood after TKR.
Material and Methods
Patients
Forty-eight patients scheduled for TKR at the Clinic of 
Orthopedics and Traumatology Lovran, Lovran, Croatia, were 
included in this prospective randomized study. The patients 
were randomly allocated using Datlnf Ranolist software (Datlnf 
GmbH, Tubingen, Germany) to 1 of 3 groups (n=16 each) ac-
cording to the type of postoperative analgesia received. The 
study included primary degenerative osteoarthritis patients who 
underwent TKR, were of American Society of Anesthesiologists 
physical statuses I to III, and provided informed consent. 
Patients aged <50 and >75 years, patients allergic to the anes-
thetics and analgesics used in this study, patients who received 
blood transfusion, patients with immunological and malignant 
disease, and those with secondary form of knee osteoarthritis 
and rheumatoid arthritis were excluded (Figure 1). The study 
was approved by the local ethics committee of the Clinic for 
Orthopedics and Traumatology Lovran, Lovran, Croatia and 
the Faculty of Medicine, University of Rijeka, Rijeka, Croatia 
according to the World Medical Association criteria in the dec-
laration of Helsinki. Healthy, sex- and age-matched volunteer 
blood donors comprised the control group (Group 0, n=16). 
All subjects provided written informed consent.
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Demographic data on sex, age, operative duration, anesthesia 
duration, and duration of hospitalization were recorded. The 
subjective perception of pain intensity for each patient was 
assessed using a 10-cm visual analogue scale (VAS) with end-
points labeled “no pain“ and “the worst possible pain“ before 
surgery (T1), immediately after surgery (T2), and 24 h (T3) and 
72 h (T4) after surgery at rest and on movement.
Anesthesia procedure
For all patients, the same anesthesia procedure was applied. 
Twelve hours before surgery, 3800 IU of dalteparin (Fraxiparine; 
Aspen Pharma Trading Limited, Braine-L’Alleud, France) was 
administered subcutaneously, and 10 mg diazepam (Roche, 
Basel, Switzerland) was administered orally. The same surgeon 
and anesthesiologist performed all operations and anesthe-
tization. All patients underwent regional lumbar spinal anes-
thesia, before which 3 mg of midazolam (Midazolam 5 mg/mL; 
B. Braun Melsungen AG, Germany) was administered to all 
patients intravenously as premedication. The lumbar spinal 
anesthetization was performed in an aseptic condition with 
patients in the lateral decubital position, using an atraumat-
ic 25-G needle. When the subarachnoid space was reached, 3 
mL of 0.5% bupivacaine (Marcaine 0.5% Spinal; Astra Zeneca, 
Courbevoie, France) was applied. A midline approach at the 
L3–L4 level was used for spinal blockade.
Postoperative analgesia
Postoperative pain was managed with epidural analgesia 
(Group 1, n=16), blockade of sciatic and femoral nerves (Group 
2, n=16), or multimodal systemic analgesia (Group 3, n=16). In 
Group 1, the epidural catheter was applied immediately after 
surgery with an 18-gauge Tuohy epidural needle (Espocan; B. 
Braun Melsungen, Germany) through loss-of-resistance tech-
nique with air. It was inserted between the L3-L4 lumbar ver-
tebrae, with the catheter tip located 2–3 cm cranially in the 
epidural space. Immediately after catheterization, continuous 
epidural analgesia was initiated. A mixture of 0.25% levobupi-
vacaine (Chirocaine 0.5%; AbbVie S.r.l. Campoverde Di Aprilia, 
Italy) and 0.5 μg/mL sufentanil (Sufentanil Renaudin, Paris, 
France) (2–15 mL/hour depending on the patient’s VAS score) 
was applied. After 24 h, intermittent epidural boluses of 10 
mL 0.25% levobupivacaine every 4–6 h (depending on the pa-
tient’s VAS score) were applied. The catheter was removed on 
postoperative day 3. In Group 2, peripheral nerve blockade of 
sciatic and femoral nerves in the operated leg was used. The 
blocks were performed using ultrasound-guided “in plane” tech-
nique for displaying the needle on an ultrasound instrument 
(Sonosite EDGE Ultrasound system; SonoSite Inc., WA, USA). 
Sciatic blockade was performed in the lateral recumbent posi-
tion with knee and hip flexure. By setting the ultrasound con-
vex 2–5-MHz transducer (C60x/5-2MHz transducer; SonoSite, 
Washington, USA) in the subgluteal region and displaying the 
sciatic nerve in the line formed by the ischial tuberositas and 
posterior superior iliac spine, a 22-gauge, 100-mm-long neuro-
stimulator needle (StimuplexR A; B. Braun Melsungen, Germany) 
connected to the nerve stimulator (StimuplexR HNS 12; B. Braun 
Melsungen, Germany) was inserted for easy identification of 
the nerve (0.5–1 mA, 0.1 millisecond). The needle was posi-
tioned near the sciatic nerve and 20 mL of 0.5% levobupiva-
caine was injected. The femoral blockade was performed in 
the supine position, using a high-frequency linear ultrasound 
probe (HFL50x/15-6-MHz Transducer; SonoSite, WA, USA), 
without nerve stimulation. The transducer was placed in the 
inguinal region and the femoral nerve was identified. Femoral 
nerve blockade was assessed with 10 mL of 0.5% levobupiva-
caine near the nerve. After bolus injection, the femoral cathe-
ter (Contiplex Tuohy; B. Braun Melsungen, Germany) was set 
up under the femoral nerve. The catheter tip was placed 3–4 
cm from the needle tip. Intermittent boluses of 10 mL 0.25% 
levobupivacaine every 4 to 6 h daily were applied on the fem-
oral catheter based on VAS score. The catheter was removed 
on postoperative day 3. In Group 3, multimodal systemic an-
algesia was used to manage postoperative pain. Initially, dur-
ing surgical wound closure, paracetamol (Paracetamol Kabi; 
Fresenius Kabi, Friedberg, Germany) was intravenously admin-
istered. Postoperative pain in these patients was managed with 
intravenously administered 1 g paracetamol every 6 h, 200 mg 
tramadol every 10–12 h (Tramal; Grunenthal GmbH, Aachen, 
Germany), and 2.5 g metamizolsodium (Alkagin; Alkaloid-Int 
d.o.o., Ljubljana, Slovenia).
Randomized (n=48)
Group 2: Sciatic and
femoral nerve blocks
 (n=16)
Group 1: Epidural
analgesia
 (n=16)
Patients included:
 (n=16)
Patients included:
 (n=16)
Patients included:
 (n=16)
Group 3: Systemic
multimodal analgesia
 (n=16)
Excluded (n=5)
• Not meeting
   inclusion criteria (n=1)
• Declined to participate (n=3)
• Other reasons (n=1)
Assessed for eligiblity (n=53)
Figure 1. Flow diagram of the study.
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Isolation of peripheral blood mononuclear cells (PBMCs)
We drew 20-ml blood samples from each patient. Blood was 
overlaid onto Lymphoprep (Lymphoprep; Fresenius Kabi, Oslo, 
Norway). PBMCs were isolated through a centrifugation procedure.
Cell surface and intracellular labeling of PBMCs
The isolated PBMCs (2×105/sample) were incubated for 20 min 
at room temperature (RT) with 10% heat-inactivated human 
AB serum to block non-specific Fc receptor binding. Then, the 
cells were washed in fluorescence-activated cell sorting (FACS) 
buffer containing NaCl (140 mM), KH2PO4 (1.9 mM), Na2HPO4 
(16.5 mM), KCl (3.75 mM) (all from Kemika, Zagreb, Croatia), 
Na2-EDTA (0.96 mM) (Fluka, Buchs, Switzerland), and NaN3 (1.5 
mM) (Difco, Detroit, MI, USA) and were fixed with 4% parafor-
maldehyde (pH 7.4) for 10 min at RT. Thereafter, the cells were 
washed twice in FACS buffer and permeabilized for 20 min at 
RT with saponin buffer (0.1% saponin; Sigma, Poole, Dorset, 
USA), 2% goat serum in phosphate-buffered saline (PBS; NaCl 
8 g, KCl 0.2 g, Na2HPO4·12H2O 2.87 g, and KH2PO4 0.2 g (all 
from Kemika, Zagreb, Croatia) dissolved in 1 L of distilled wa-
ter). To appropriate cell samples (3 µg diluted in 200 µl of sa-
ponin buffer), mouse dG9 IgG2b anti-perforin monoclonal an-
tibody or isotype-matched control (mouse MA-21, IgG2b; BD 
Biosciences, Erembodegem, Belgium) conjugated with fluores-
cein isothiocyanate (FITC) was added and incubated at +4°C 
for 30 min. Then, the samples were washed twice with sapo-
nin buffer and resuspended in 1 mL of FACS buffer. A com-
bination of CyChrome Phycoerythrin-5 (Cy-PE5) conjugated 
anti-CD3 (mouse UCHT1, IgG1) and PE-conjugated anti-CD4 
mAb (mouse RPA-T4, IgG1), Cy-Pe5 anti-CD3 and PE anti-CD8 
(mouse RPA-T8, IgG1), or Cy-Pe5 anti-CD3 and PE anti-CD56 
(mouse B159, IgG1) were used for surface labeling. As con-
trols, we used PE-, FITC-, or CY-PE5-conjugated mouse isotype-
matched antibodies (all from eBioscience, San Diego, CA, USA). 
After fixing the labeled samples in 400 μL of 2% paraformalde-
hyde, they were analyzed using flow cytometry (FACSCalibur; 
BD Biosciences, San Jose, CA, USA).
Statistical analysis
Statistical analysis was performed using Statistica 13.3 soft-
ware (TIBCO Software Inc., Palo Alto, CA, USA). The Kolmogorov-
Smirnov test was used to test for normal distribution of the 
data. Non-parametric tests were used because the data did 
not demonstrate normal distribution. Friedman’s test and the 
post hoc Wilcoxon rank sum test were used to compare time 
points within groups. Kruskal-Wallis test was used to analyze 
differences among groups, followed by Mann-Whitney U-test 
for post hoc analysis. Bonferroni adjustments were applied 
when multiple comparisons were made.
We calculated the minimum required sample size based on 
preliminary results obtained for the 3 groups. As we com-
pared the 3 patient groups, we used sample size calculation 
in Statistica, option several means. We set type I error rate (al-
pha) at 0.05, power goal at 0.80, RMSSE at 0.6, and the non-
centrality parameter (delta) at 7.2. The analysis indicated that 
15 patients in each group were required. Correlation between 
VAS values and the frequency of different leukocyte subpopu-
lations and percentage of perforin expression was tested us-
ing Spearman’s rank correlation coefficient. A difference was 
judged to be statistically significant at p<0.05. All data are pre-
sented as the 25th–75th percentile values.
Results
Clinical parameters
Demographic and surgical data are shown in Table 1. There 
were no significant differences among Groups 1, 2, and 3 re-
garding age, sex, operation duration, or anesthesia duration.
Comparison of VAS scores at rest and on movement
Table 2 shows the VAS scores for Groups 1, 2, and 3 at rest and 
on movement at different time points (T1, T2, T3, and T4). VAS 
Group 1 Group 2 Group 3 P value
Age (years)*  68.5 (64–72)  67 (62–70)  70.5 (64–74.5) Ns
Gender (M/F) 6/10 6/10 7/9 Ns
Duration of surgery (min)  72.5 (65–88.5)  67.5 (64.5–77.5)  65.5 (60–73) Ns
Duration of anaesthesia (min)  316 (277.5–407.5)  339 (299–369.5)  318 (294–359.5) Ns
Table 1. Demographic and clinical parameters of patients in all groups.
Group 1: patients received epidural analgesia; Group 2: patients received sciatic and femoral nerve block; Group 3: patients received 
multimodal systemic analgesia. Data are presented as median (25th–75th percentile). Differences between groups were not significant 
(NS; p>0.05).
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scores at rest and on movement recorded at T1 did not differ 
significantly. In Group 1, the VAS score on movement was sig-
nificantly higher at T3 and T4 than at T2. In Group 2, the VAS 
score on movement was significantly higher at T4 than at T2. 
VAS scores in Group 3 were significantly higher at T2, T3, and 
T4 than at T1 at rest and on movement. At T2, the VAS score 
was significantly higher in Group 3 than in Groups 1 and 2 at 
rest and on movement. At T3, the VAS score was significantly 
higher in Group 3 than in Groups 1 and 2 at rest and on move-
ment. At T4, the VAS score was significantly higher in Group 
3 than in Groups 1 and 2 on movement.
Effects of different types of postoperative analgesia on the 
frequency of T lymphocytes and their subsets
The frequencies of T lymphocytes (determined as CD3+CD56– 
cells), NK cells (CD3–CD56+ cells), and NKT cells (CD3+CD56+ 
cells) did not differ significantly before surgery (T1) among 
groups (Figure 2A). At T2, the frequencies of T lymphocytes 
and their CD3+CD4+ and CD3+CD8+ subsets, as well as NK cells, 
were significantly lower in Group 3 than in Groups 1 and 2 
(Figure 2B). At T3, the frequencies of CD3+ and the CD3+CD8+ 
subset were lower in Group 3 than in Group 2 (Figure 2C). 
The frequency of CD3+CD8+ cells was lower in Group 3 than in 
Group 2 at T4 (Figure 2D), while at T3 the frequency of NK cells 
was significantly lower in Group 3 than in Groups 1 and 2 at 
T3 (Figure 2C) and T4 (Figure 2D). The frequencies of NK cells 
and their subsets CD3–CD56+bright and CD3–CD56+dim (Figure 3C) 
did not differ significantly among groups (data not shown).
Effects of different types of postoperative analgesia on 
perforin expression in peripheral blood lymphocytes
Figure 3 shows the changes in perforin+ cell frequency at dif-
ferent time points. Perforin+ cell frequency was significantly 
lower in Group 3 than in Groups 1 and 2 at T3 and T4.
Perforin-expressing CD3+ cells and their CD3+CD8+ subset were 
lower in Group 3 than in Groups 1 and 2 at T3 (Figure 4C) 
and T4 (Figure 4D). Perforin-expressing CD3+CD4+ and NKT 
cells (Figure 4), as well as NK cells and their subsets (data not 
shown), did not differ significantly at any time point.
Correlation between VAS values and frequencies and 
perforin expression of different leukocyte subpopulations
VAS values were negatively correlated with the frequencies of 
CD3+, CD3+CD4+, CD3+CD8+, and CD3+CD56+ cells at both T2 and 
T3 (Table 3). At T3 and T4, a negative correlation was found 
between VAS values and all perforin-positive, CD3+perforin+, 
and CD3+CD8+ perforin+ cells (Table 3).
Discussion
Pain management after TKR is mandatory but usually diffi-
cult [1], and there are currently no unique postoperative pain 
management approaches. Despite the reported impacts of dif-
ferent methods of postoperative analgesia in patients under-
going major thoracic and abdominal surgery on cellular- and 
molecular-level alterations in the immune response, few stud-
ies exist on patients undergoing TKR [13,19,22,23]. Here, we 
report reductions in the frequency of circulating T lympho-
cytes, their subsets CD3+CD4+ and CD3+CD8+ cells, and NKT 
Table 2. Comparison of visual analogue scores (VAS) at rest and on movement in patients of all groups.
Data are presented as median (25th–75th percentile). Statistical significance is shown by p-values between VAS on movement at T2 
and T3 (a), T2 and T4 (b) in Group 1, at T2 and T4 in Group 2 (c), T1 and T2 (d), T1 and T3 (e), and T1 and T4 (f) in Group 3. Statistical 
significance between VAS scores at rest in Group 3 between T1 and T2 (g), T1 and T3 (h), and T1 and T4 (i) in Group 3 is shown. When 
comparing VAS values between groups, statistical significance is presented using p-values as follows: * between Group 2 and Group 
3 at T2, between Group 1 and Group 3 at time T2, #  between Group 1 and Group 3 at T3, $ between Group 2 and Group 3 at time T3, 
& between Group 1 and Group 3 at T4,% and between Group 2 and Group 3 at T4. * p<0.05. VAS – visual analogue scale; T1 – before 
surgery; T2 – after surgery; T3 – 24 h after surgery; T4 – 72 h after surgery.
Group 1 Group 2 Group 3
P value
T1 T2 T3 T4 T1 T2 T3 T4 T1 T2 T3 T4
VAS at 
rest
0
(0–0)
0
(0–1)°
0.5
(0–2.5)#
0
(0–1)
0
(0–0)
0
(0–0)*
0.5
(0–1)$
0
(0–2)
0
(0–0)g,h,i
1
(0–3.5)
3
(2.5–4)
1.5
(0.5–3.5)
g,h,i,
°,*,#,$
p<0.05
VAS on 
movement
0
(0–1)
0
(0–1)a,b,°
1.5
(0.5–3)#
1
(0–3)&
0
(0–1)
0
(0–0)c,*
1
(0–2)$
2
(0–3)%
0
(0–1)d,e,f
2
(0.5–6)
4
(3–5)
4
(2.5–4)
a,b,c,d,e,f
°,#,*,&,$,%
p<0.05
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cells in patients receiving multimodal systemic analgesia com-
pared to regional analgesia. These findings indicate that both 
regional epidural analgesia and blockade of sciatic and fem-
oral nerves efficiently maintain cell-mediated immunity after 
TKR. Strong negative correlations between pain and decreas-
es in circulating T lymphocytes of both the CD3+CD4+ and the 
CD3+CD8+ phenotype and NKT cells were observed immedi-
ately and 24 h after surgery in patients with multimodal sys-
temic, but not regional analgesia. The strong negative corre-
lation found between pain intensity and perforin-expressing 
cytotoxic CD3+CD8+ T lymphocytes confirmed the suppression 
of cell-mediated immunity against intracellular antigens, such 
as viruses and fungi.
Pro-inflammatory cytokines modulate pain intensity in a dose-
dependent manner. Enhanced stimulation of nociceptors and 
pain recognition in the brain lead to activation of the hypotha-
lamic-pituitary axis [26] and the sympathetic and parasympa-
thetic nerve systems [27], which are involved in the decrease 
in cell-mediated immune response and lymphocyte count. In 
turn, pain induces the synthesis of CRP, cytokines, and chemo-
kines at the site of surgical injury, which might support local 
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Figure 2.  Frequencies of CD3+, CD3+CD4+, CD3+CD8+, and CD3+CD56+ cells in peripheral blood lymphocytes in Group 1 (), Group 2 (), 
and Group 3 (=) at time points T1 (before surgery) (A), T2 (immediately after surgery) (B), T3 (24 h after surgery) (C), and 
T4 (72 h after surgery) (D). Data are presented as median (), 25th–75th percentile (), non-outlier range (I), and outliers (). 
* p<0.05.
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Figure 3.  Frequencies of perforin-positive cells within peripheral blood lymphocytes in Group 1 (), Group 2 (), and Group 3 (=) at 
times points T1 (before surgery), T2 (immediately after surgery), T3 (24 h after surgery), and T4 (72 h after surgery). Data are 
presented as median (), 25th–75th percentile (), non-outlier range (I), and outliers (). * p<0.05.
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recruitment of immune cells at the site of pain [26]. Locally 
recruited cells, predominantly cytotoxic CD3+CD8+ lympho-
cytes and NK cells, could be responsible for elimination of in-
jured or strongly activated cells. The cytotoxic activity might 
be mediated by perforin [25]. Perforin is one of the main cy-
totoxic mediators of cell-mediated immunity and its downreg-
ulation in peripheral blood is associated with increased inci-
dence of systemic infection and poor patient outcome [24]. 
Here, a greater decrease in perforin was observed in patients 
receiving systemic multimodal analgesia than in those receiv-
ing regional analgesia. This was prominent in T lymphocytes, 
predominantly those with the cytotoxic CD3+CD8+ phenotype.
In patients receiving peripheral nerve blockade, the mainte-
nance of T lymphocytes, NKT cells, NK cells, and their subsets, 
as well as perforin expression, in the early postoperative pe-
riod could be explained by prolonged blockade of C-fibers of 
afferent and efferent nerves with local anesthetics, thereby 
reducing central nervous system stimulation and subsequent 
neuro-immunomodulation induced by locally produced pro-
inflammatory and pain-inducing cytokines [28–32]. We can-
not exclude the possibility that local anesthetics themselves 
modulate the inflammatory response locally and systemically. 
However, we did not find significant fluctuation in NK cells 
(data not shown).
The present results agree with previous findings that patients 
receiving regional analgesia, including peripheral nerve block-
ade or epidural analgesia, experience lesser hyperalgesia than 
those receiving systemic multimodal analgesia [13,33]. In line 
with these results, techniques of regional analgesia, predomi-
nantly epidural postoperative analgesia, can significantly reduce 
altered inflammatory responses in the early postoperative pe-
riod after major thoracic, abdominal, and orthopedics surgery 
[13,19,34,35]. By measuring blood glucose, insulin, and corti-
sol levels, as well as leukocyte count, as inflammatory markers, 
Bagry et al. found that continuous lumbar plexus and sciatic 
peripheral nerve block effectively reduces pain after TKR and 
can attenuate distinct inflammatory responses [28]. Song et al. 
reported that epidural analgesia produces milder deleterious 
effects on cell-mediated immunity in critically ill patients after 
tumor resection surgery [36]. Our results suggest that main-
taining an appropriate balance of the immune system through 
careful management of postoperative analgesia after TKR can 
improve patient prognosis, although in our patients, complica-
tions such as delayed wound healing and infection did not occur.
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Figure 4.  Frequencies of CD3+perforin+, CD3+CD4+perforin+, CD3+CD8+perforin+ and CD3+CD56+perforin+ cells within peripheral blood 
lymphocytes in Group 1 (), Group 2 (), and Group 3 (=) at times points T1 (before surgery) (A), T2 (immediately after 
surgery) (B), T3 (24 h after surgery) (C), and T4 (72 h after surgery) (D). Data are presented as median (), 25th–75th percentile 
(), non-outlier range (I), and outliers (). * p<0.05.
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Conclusions
Our results suggest that peripheral nerve blockade or epidural 
analgesia are better and more effective in maintaining perfo-
rin-expressing peripheral blood T lymphocytes with cytotoxic 
CD3+CD8+perforin+ phenotype and NKT cells than multimodal 
systemic analgesia after TKR in the early postoperative period.
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Comparison
VAS
T2 T3 T4
r p r p r p
CD3+ cells –0.538 0.038 –0.0617 0.014 0.178 0.525
CD3+CD4+ cells –0.083 0.001 –0.0648 0.009 0.078 0.78
CD3+CD8+ cells –0.078 0.001 –0.063 0.012 –0.448 0.093
CD3+CD56+ cells –0.078 0.001 –0.494 0.041 –0.616 0.054
CD56+ cells –0.028 0.92 0.124 0.659 –0.454 0.089
CD56dim+ cells –0.999 0.72 0.377 0.16 –0.17 0.54
CD56bright cells –0.998 0.726 –0.193 0.48 –0.08 0.77
Perforin+ cells –0.403 0.136 –0.445 0.05 –0.442 0.048
CD3+perforin+ cells –0.624 0.13 –0.463 0.05 –0.736 0.002
CD3+CD4+perforin+ cells –0.14 0.616 –0.09 0.72 –0.266 0.33
CD3+CD8+perforin+ cells –0.678 0.051 –0.774 0.001 –0.672 0.006
CD3+CD56+perforin+ cells –0.512 0.052 –0.157 0.575 0.135 0.63
CD56+perforin+ cells –0.385 0.156 –0.235 0.398 –0.291 0.358
CD56dim+perforin+ cells –0.298 0.296 –0.375 0.17 –0.408 0.13
CD56bright+perforin+ cells 0.36 0.183 –0.484 0.067 –0.549 0.054
Table 3.  Correlation between VAS values and different lymphocytes subpopulation or their perforin expression after surgery (T2), 24 
(T3), and 72 (T4) h.
Statistical significance is shown as p and r values.
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